Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
NCT03524677
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DIAGNOSTIC_TEST:
Liquid Biopsy
Sponsor
University of Roma La Sapienza
Collaborators
[object Object]